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540 Abstracts August 2014Conclusions: Sn-renals angled more inferiorly than F-renals due
to patient selection and stent conﬁguration. Upward respiratory-
induced deformation of the celiac artery exceeded that of stented re-
nals, likely related to lack of intravascular stent placement. Sn-renals
exhibited signiﬁcant curvature change during respiration, a ﬁnding
that may warrant increased surveillance based on known mechanisms
of stent-induced renal artery thrombosis. Further investigation is war-
ranted to better optimize anatomic, patient, and branch vessel stent
type selection between fenestrated and snorkel strategies and their rela-
tionship to long-term patency.
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Zenith p-Branch Fenestrated Endovascular Graft: How Close “Off-
the-Shelf ” Repair for Asian Patients with Juxtarenal Aortic
Aneurysms?
Jiale Ou, Stephen WK. Cheng. Surgery, The University of Hong Kong,
Hong Kong, China
Objective: The Zenith pivot branch fenestrated endovascular graft
(p-branch) is a new “off-the-shelf” device to treat patients with juxtarenal
aortic aneurysms (JRA). Two options are currently available based on
Caucasian anatomy, differing in the longitudinal distance between the supe-
rior mesenteric artery (SMA) and the renal fenestrations. This study inves-
tigates the anatomical suitability of the P-branch fenestrated grafts in a
cohort of Asian patients with JRA.
Methods: Computed tomography images of 51 consecutive pa-
tients (43 men; mean age, 76.8 years) with JRA from our hospital
database, were analyzed using the TeraRecon Aquarius workstation
(San Mateo, Calif). The renal clock positions differed with the variation
in graft diameters (range, 26-36 mm). Using the native paravisceral
aortic diameter as reference, the artery positions were converted to
circumferential locations and then mapped together with the diameters
of corresponding arteries. Their geometric locations were then applied
to the P-branch option A and B (single SMA and two renal fenestra-
tions, and a scallop). The suitability of these stent graft designs to
the aneurysm was evaluated.Fig. The three black circles represent the pivot fenestrations of the superior
mesenteric artery and the two renal arteries, and the rectangle is the scallop.
The ﬁlled circles stand for the celiac trunk (green) and left (red) and right
(blue) renal arteries. The size of the circles represents the actual diameter of
the corresponding artery. A, Perfectly suitable: all the visceral oriﬁces
located inside the fenestrations or scallop. B,Marginally suitable: part of the
renal oriﬁce (left) located outside the fenestration. C and D, Candidates for
the 26-mm and 30-mm graft, respectively.Results: A total of 31 JRA patients (60.8%) were regarded as suit-
able candidates for one or both p-branch endografts (20 with option
A, 22 with option B, and 11 with both options). In 35 patients
(68.6%), both renal arteries could be aligned with the fenestrations.
Among them, 16 patients (31.4%) were perfectly matched, while
19 patients (37.2%) were only marginally suitable (Fig). The major
reason for the exclusion was the misalignment of the renal pivots,
mainly due to the longitudinal position of renal arteries rather than the
circumferential position, particularly the longer distance of the right
renal arteries from the SMA. If the right renal fenestration of option B
was adjusted to 20-mm caudal to the SMA fenestration (level with the
left fenestration), the match could reach 78.4% (40 of 51). Other
reasons were unsuitable scallops for the celiac axis in four patients
(7.84%) and insufﬁcient length of the abdominal aorta to accommodate
the graft in another four patients.
Conclusions: The present designs of the p-branch fenestrated graft
are suitable for a good proportion of JRA patients in Asia. Further reﬁne-
ment of design may be necessary to accommodate the anatomical variations,
especially a lower right renal artery.
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Initial Experience with Endovascular Treatment of Thoracoabdominal
Aortic Aneurysm Using Physician-Modiﬁed Endografts: B-TEVAR
IDE Study
Matthew P. Sweet, MD, Benjamin W. Starnes, MD, Billi Tatum, RN,
CRCC. University of Washington, Seattle, Wash
Objective: This study reports an initial single-center experience of pa-
tients with physician-modiﬁed thoracic endografts for endovascular treat-
ment of thoracoabdominal aortic aneurysm (TAAA).
Methods: Patients were included if treated urgently for symptomatic
TAAA (n ¼ 2) as well as those treated in a Phase 1 clinical trial (n ¼ 11), an
Food and Drug Administration-approved physician sponsored investiga-
tional device exemption (B-TEVAR IDE). Patients were included if they
had a TAAA and were deemed to be at high risk with open repair and
met study inclusion criteria.
Results: Thirteen patients (nine men and four women) with TAAA
were treated with branched-fenestrated endovascular stent grafts. Demo-
graphic and operative details are reported in Tables I and II. Nine pa-
tients (69%) had successful treatment: return to preoperative functional state
and complete aneurysm exclusion at mean 8 months (range, 1-28 months)
of follow-up. Two patients (15%) died. One patient died on the 22nd
postoperative day of complications of spinal cord ischemia. Another patient
died 4 months after repair of bacterial endocarditis from a foot infection.
One other patient had successful aneurysm exclusion but suffered perma-
nent spinal cord injury. One patient is clinically well despite presence of a
type III endoleak.
Conclusions: Totally endovascular treatment of TAAA using a
physician-modiﬁed thoracic endograft is feasible. Although it can be
done using minimally invasive means, it remains a high-risk procedure.
B-TEVAR is highly adaptable to complex anatomy and can be done
with current commercially available devices. This treatment may pro-
vide a safe and effective means of treatment of TAAA among patients
at high risk of open repair. This early experience has provided insights
into the safe conduct of these procedures, including staged repair, and
methods of case planning.Table I. Demographics
Variables Mean (range) or No. (%) (n ¼ 13)







Diameter, cm 6.8 (5.5-9.1)
Symptomatic 2 (15)
Prior aortic operation 5 (38)
TAAA, Thoracoabdominal aortic aneurysm.




Percutaneous access 13 (100)
Branches, No. 3.8 (2-4)
Estimated blood loss, mL 226 (50-500)
Length of aortic coverage, cm 37 (21-56)
Aortic coverage (LSCA to bifurcation) 77 (46-100)
Contrast volume, mL 176 (60-295)
Fluoroscopy time, min 64 (35-128)
LSCA, Left subclavian artery.









Open 254 (70) 89 (33) 46 (20)
Endovascular aneurysm
repair
107 (30) 182 (67) 189 (80)
Clamp location
Supraceliac 17 (7) 10 (11) 9 (20)
Suprarenal 6 (2) 19 (21) 17 (37)
Between renal arteries 7 (3) 4 (4) 4 (9)
Infrarenal (<2 cm neck) 132 (52) 39 (44) 13 (28)




9 (4) 13 (15) 22 (48)
Renal artery bypass 8 (3) 7 (8) 15 (33)
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Physician-Modiﬁed Endovascular Grafts: Graft Creation
Benjamin W. Starnes, MD, Gale Tang, MD, Billi Tatum, RN. Surgery,
University of Washington, Seattle, Wash
Objective: The purpose of this video minipresentation is to describe
in exquisite detail the process of physician-modiﬁed endovascular graft
(PMEG) creation in high deﬁnition as part of an Food and Drug Adminis-
tration-sanctioned investigational device exemption clinical trial.
Methods: A high-deﬁnition 4-minute video was created and edited
describing in detail the creation of a PMEG to successfully treat a large jux-
tarenal aortic aneurysm.
Results: The PMEG graft was successfully created and implanted.
Conclusions: Three-vessel custom made fenestrated devices can be
created in <1 hour with appropriate technique.
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The Impact of Endovascular Repair (EVAR) of Abdominal Aortic
Aneurysms (AAA) on Resident Training in Elective Open Aneurysm
Repair
Michael P. Harlander-Locke, MPH, Peter F. Lawrence, MD, William
Quinones-Baldrich, MD, Wesley S. Moore, MD. University of California,
Los Angeles, Los Angeles, Calif
Objective: The use of endovascular aneurysm repair (EVAR) to treat
abdominal aortic aneurysms (AAAs) has resulted in a declining number and
increased the complexity of open AAA surgery. Our objective was to analyze
trends in open repair of AAA over the last 15 years at our institution and
assess its effect on resident training.
Methods: A retrospective review of 867 consecutive AAA done
over the last 15 years at our institution was performed, recording
type of repair, level of aortic clamping, and associated bypasses. A sur-
vey of all vascular surgery program directors was used to assess their
willingness to assist vascular surgery residents in variously complex
open AAA repairs.
Results: The number of open repairs of AAA has declined by 80%
over 15 years (Table). The complexity of open AAA repair has resulted
in more suprarenal and supraceliac clamping (P < .001) and more renal
and visceral artery revascularization and bypass (P < .001). The will-
ingness of attendings (67) to assist vascular surgical residents varied
signiﬁcantly between trainees in fellowship and integrated programs (P
< .05). Attendings are signiﬁcantly less willing to assist a postgraduate
year 4/5 in an integrated vascular residency with complex open op-
erations compared with a ﬁrst-year or second-year vascular fellow (P <
.05).
Conclusions: Our experience documents that vascular surgical resi-
dents are exposed to progressively fewer open aneurysm cases. AAA cases
are increasingly complex and often considered too difﬁcult, thus decreasing
resident involvement. Vascular surgery programs will need to consider sup-
plemental open AAA training, such as simulation or traveling to high-vol-
ume centers, or both, for trainees to achieve competency in open AAA
surgery.Author Disclosures: M. P. Harlander-Locke: None; P. F. Lawrence:
None; W. Quinones-Baldrich: None; W. S. Moore: None.
Brachial Artery Volume Flow by Duplex Predicts Dialysis Access
Maturation
Dennis F. Bandyk, MD,1 Sae Hee Ko, MD,1 Kelley Hodgkiss-
Harlow, MD,2 John Lane III, MD,1 Andrew Barleben, MD1. 1Vascular
and Endovascular Surgery, University of California San Diego, La Jolla,
Calif; 2Kaiser Permanente San Diego, La Jolla, Calif
Objective: To validate use of our previously described Fast Five-Min-
ute Duplex Scan, which measures brachial artery volume ﬂow (VF), to
conﬁrm the adequacy of dialysis access maturation and predict successful he-
modialysis usage.
Methods: Duplex ultrasound imaging was used to directly measure
brachial artery and dialysis access VF in 75 patients with upper extremity ac-
cesses. Scatterplot analysis was used to determine the correlation between
brachial artery VF and dialysis access VF. Brachial artery velocity spectra
criteria were developed to estimate VF in three categories - low 800 mL/
min. An additional 121 patients having a primary (n ¼ 73) or revised (n
¼ 48) dialysis access had measurement of brachial VF, and this was corre-
lated with conduit maturation and hemodialysis usage. Duplex testing was
performed in the outpatient clinic within 2 to 3 weeks of the access
procedure.
Results: Duplex measurements of VF from the brachial artery demon-
strated a high degree of correlation (R2 ¼ 0.87) with access conduit VF for
autogenous vein (n ¼ 45; R2 ¼ 0.88) and bridge grafts (n ¼ 30; R2 ¼
0.85). Access VF >800 mL/min is predicted when duplex testing indicates
a brachial artery diameter >4 mm, PSV >150 cm/s, and diastolic/systolic
velocity ratio >0.3. Brachial artery VF <800 mL/min was associated with
failure of access maturation. Revision was required in 13 of 16 accesses
with VF <600 mL/min and in three of 11 with VF in the 600 to 800
mL/min range. Only one of 94 with VF >800 mL/min required revision
(for conduit depth), and all were successfully used for hemodialysis.
Conclusions: The Fast Five-Minute Duplex Scan is an accurate tech-
nique to predict upper extremity dialysis access maturation and successful
hemodialysis usage. Brachial artery VF is easy to measure, applicable to fore-
arm and arm accesses, and is highly correlated to AV access VF. VF >800
mL/min predicts a functional access suitable for cannulation if conduit anat-
omy criteria are also veriﬁed.
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Migration Towards Proximal Location Improves Maturation Rate of
Arteriovenous Fistula
Edward D. Gifford, MD, Virginia Nguyen, BS, Amy H. Kaji, MD, PhD,
Patrick Chisum, BS, Jerry Kim, MD, Annie Zeng, Ramanath
Dukkipati, MD, Christian deVirgilio, MD. Surgery, Harbor-University of
California Los Angeles Medical Center, Torrance, Calif
Objective: In recent years, vascular surgeons have noted that a major
drawback to the Fistula First initiative has been the failure of arteriovenous
ﬁstulas (AVFs) to reach maturation. In May 2012, we adopted a protocol
and hypothesized that such a protocol would lead to a decrease in ﬁstula
failures.
